	営業利益		日付
Acadia Pharmaceuticals	USD 17.39M	18.36M	2025-12
Agios Pharmaceuticals	USD -110.02M	11.55M	2026-03
Alnylam Pharmaceuticals	USD 137.59M	108.19M	2026-03
BioCryst Pharmaceuticals	USD 260.38M	230.79M	2025-12
BioMarin Pharmaceutical	USD 129.65M	68.74M	2026-03
Esperion Therapeutics	USD 85.23M	95.19M	2025-12
Immunic	USD -23.33M	2.67M	2025-12
Insmed	USD -249.71M	11.64M	2025-12
Ionis Pharmaceuticals	USD -118M	97M	2026-03
Karyopharm Therapeutics	USD -17.84M	13.44M	2025-12
Kyowa Hakko Kirin	JPY 38.35B	12.49B	2025-12
MacroGenics	USD -12.1M	30.74M	2025-12
Moderna	USD -1.39B	531M	2026-03
Neurocrine Biosciences	USD 227.9M	11.4M	2025-12
PTC Therapeutics	USD -81.62M	85.11M	2025-12
Puma Biotechnology	USD 22.08M	24.26M	2024-09
Regeneron Pharmaceuticals	USD 744.8M	153.8M	2026-03
Sarepta Therapeutics	USD -410.08M	347.2M	2025-12
Ultragenyx Pharmaceutical	USD -114M	56.89M	2025-12
Vertex Pharmaceuticals	USD 1.14B	124.5M	2026-03
Xoma	USD -15.64M	5.56M	2024-09